Details for New Drug Application (NDA): 019732
✉ Email this page to a colleague
The generic ingredient in LUPRON DEPOT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
Summary for 019732
Tradename: | LUPRON DEPOT |
Applicant: | Abbvie Endocrine Inc |
Ingredient: | leuprolide acetate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019732
Suppliers and Packaging for NDA: 019732
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 019732 | NDA | AbbVie Inc. | 0074-3642 | 0074-3642-03 | 1 KIT in 1 CARTON (0074-3642-03) * 1 mL in 1 SYRINGE * 1 SWAB in 1 PACKET |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 7.5MG | ||||
Approval Date: | Jan 26, 1989 | TE: | RLD: | Yes |
Expired US Patents for NDA 019732
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 019732-001 | Jan 26, 1989 | 5,575,987 | ⤷ Subscribe |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 019732-001 | Jan 26, 1989 | 5,716,640 | ⤷ Subscribe |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 019732-001 | Jan 26, 1989 | 4,917,893 | ⤷ Subscribe |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 019732-001 | Jan 26, 1989 | 5,480,656 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription